Causes and consequences of fever during pregnancy: A retrospective study in a gynaecological emergency department.


Journal

Journal of gynecology obstetrics and human reproduction
ISSN: 2468-7847
Titre abrégé: J Gynecol Obstet Hum Reprod
Pays: France
ID NLM: 101701588

Informations de publication

Date de publication:
Nov 2020
Historique:
received: 28 05 2020
revised: 11 08 2020
accepted: 13 08 2020
pubmed: 28 8 2020
medline: 28 8 2021
entrez: 28 8 2020
Statut: ppublish

Résumé

Fever is a very common reason for emergency consultation during pregnancy, and may be associated with maternal, obstetrical and/or fetal adverse outcomes. The aim of this study was to determine the etiologies and to analyze the maternal or fetal complications of fever in pregnancy. A retrospective single center study including all patients who consulted for fever above 38 °C during pregnancy in the gynecological emergency ward from August 2016 to July 2017. A total of 100 pregnant women who consulted for fever were included. The etiologies were common viral infections (37 %), influenza (21 %), pyelonephritis (11 %), viral gastroenteritis (6%), chorioamnionitis (5%), other (5%). The etiology was unknown for 15 %. Fever was confirmed during consultation in 45/100 patients (45 %). Among patients with confirmed fever, 21/45 (47 %) were hospitalized with a median stay of 3 days [IQR 2-4] and 10/45(22 %) developed fetal or maternal complications. Probabilistic antibiotics were delivered for 34/45, 76 % patients. Only 14/45, 31 % had confirmed bacterial infections. Of the 32 patients with confirmed fever who had no etiologic diagnosis at the initial work-up in the emergency room, 19/32, 59 % received presumptive treatment with amoxicillin against Listeria monocytogenes. None had confirmed listeriosis, and all were probably common viral infections. Among all patients, the complications rate was 13 % and 22 % in the subgroup with fever confirmed at presentation. This study quantifies the main etiologies and complications of fever during pregnancy. A challenge is to reduce excessive antibiotic use by improving rapid diagnosis of bacterial and viral infections. Prospective studies are needed to target patients at risk of complications in an optimal way and to study new management strategies.

Identifiants

pubmed: 32853830
pii: S2468-7847(20)30256-7
doi: 10.1016/j.jogoh.2020.101899
pmc: PMC7444605
pii:
doi:

Substances chimiques

Anti-Bacterial Agents 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

101899

Informations de copyright

Copyright © 2020 Elsevier Masson SAS. All rights reserved.

Références

PLoS One. 2019 Jun 14;14(6):e0217651
pubmed: 31199828
Euro Surveill. 2018 Feb;23(5):
pubmed: 29409569
BMC Med. 2016 Jun 17;14(1):91
pubmed: 27312712
BJOG. 2015 Apr;122(5):663-71
pubmed: 24862293
J Clin Microbiol. 2004 Nov;42(11):5184-8
pubmed: 15528713
Eur J Clin Microbiol Infect Dis. 2011 Dec;30(12):1497-502
pubmed: 21556677
Gynecol Obstet Fertil Senol. 2017 Apr;45(4):231-237
pubmed: 28373042
Lancet. 2016 Jan 9;387(10014):168-75
pubmed: 26603918
Eur J Clin Microbiol Infect Dis. 2013 Jan;32(1):107-13
pubmed: 22907333
Am J Perinatol. 2016 Dec;33(14):1337-1356
pubmed: 27159203
BMC Infect Dis. 2019 Aug 2;19(1):683
pubmed: 31375073
JAMA. 2016 Aug 23-30;316(8):846-57
pubmed: 27552618
J Matern Fetal Neonatal Med. 2018 Jun;31(11):1418-1425
pubmed: 28391772
Gynecol Obstet Fertil Senol. 2018 Dec;46(12):1054-1067
pubmed: 30389543
N Engl J Med. 2002 Jul 25;347(4):240-7
pubmed: 12140299
J Med Virol. 2013 Aug;85(8):1473-7
pubmed: 23722328
Eur J Clin Microbiol Infect Dis. 2020 May;39(5):999-1002
pubmed: 31955353
Lancet Infect Dis. 2017 May;17(5):510-519
pubmed: 28139432
Am J Obstet Gynecol. 2017 Jun;216(6):596.e1-596.e5
pubmed: 28216060
Am J Obstet Gynecol. 2014 Mar;210(3):219.e1-6
pubmed: 24100227
Diagn Microbiol Infect Dis. 2013 Jul;76(3):255-61
pubmed: 23601453

Auteurs

C Egloff (C)

Assistance Publique-Hôpitaux de Paris APHP.Nord, Service de gynécologie obstétrique, Hôpital Louis Mourier, 178 rue des Renouillers, 92701, Colombes cedex, France; FHU PREMA, France; Université de Paris, Paris, France; INSERM, IAME, UMR 1137, Paris, France. Electronic address: Charles.egloff@gmail.com.

J Sibiude (J)

Assistance Publique-Hôpitaux de Paris APHP.Nord, Service de gynécologie obstétrique, Hôpital Louis Mourier, 178 rue des Renouillers, 92701, Colombes cedex, France; FHU PREMA, France; Université de Paris, Paris, France; INSERM, IAME, UMR 1137, Paris, France.

C Couffignal (C)

Unité de recherche clinique Paris Nord Val de Seine, URC PNVS, France; Université de Paris, Paris, France; INSERM, IAME, UMR 1137, Paris, France.

L Mandelbrot (L)

Assistance Publique-Hôpitaux de Paris APHP.Nord, Service de gynécologie obstétrique, Hôpital Louis Mourier, 178 rue des Renouillers, 92701, Colombes cedex, France; FHU PREMA, France; Université de Paris, Paris, France; INSERM, IAME, UMR 1137, Paris, France.

O Picone (O)

Assistance Publique-Hôpitaux de Paris APHP.Nord, Service de gynécologie obstétrique, Hôpital Louis Mourier, 178 rue des Renouillers, 92701, Colombes cedex, France; FHU PREMA, France; Université de Paris, Paris, France; INSERM, IAME, UMR 1137, Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH